Roth Capital Has Optimistic View of Allstate FY2025 Earnings

Key Points

• Roth Capital increased Allstate’s FY2025 earnings per share estimate from $18.00 to $20.30, with a Q4 2026 estimate of $7.40 EPS.
• Allstate reported $5.94 EPS for the last quarter, surpassing the consensus estimate of $3.20, with quarterly revenues of $15.05 billion.
• The company declared a quarterly dividend of $1.00 per share, yielding 2.0%, payable on October 1st to stockholders of record on August 29th.

The Allstate Corporation (NYSE:ALL - Free Report) - Research analysts at Roth Capital boosted their FY2025 EPS estimates for Allstate in a note issued to investors on Thursday, July 31st. Roth Capital analyst H. Fong now forecasts that the insurance provider will post earnings per share of $20.30 for the year, up from their previous forecast of $18.00. The consensus estimate for Allstate's current full-year earnings is $18.74 per share. Roth Capital also issued estimates for Allstate's Q4 2026 earnings at $7.40 EPS.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share for the quarter, topping the consensus estimate of $3.20 by $2.74. The firm had revenue of $15.05 billion during the quarter, compared to the consensus estimate of $16.59 billion. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The company's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.61 EPS.

ALL has been the topic of several other reports. Raymond James Financial reaffirmed a "strong-buy" rating and set a $260.00 target price (up from $250.00) on shares of Allstate in a research note on Monday. William Blair assumed coverage on shares of Allstate in a research note on Friday, June 6th. They set a "sector outperform" rating on the stock. Evercore ISI upped their target price on shares of Allstate from $227.00 to $230.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. BMO Capital Markets reaffirmed an "outperform" rating on shares of Allstate in a research note on Friday, May 16th. Finally, Barclays reissued an "underweight" rating and issued a $198.00 price objective (up from $188.00) on shares of Allstate in a research report on Thursday, July 31st. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $229.40.

Allstate Trading Up 1.2%

Shares of NYSE:ALL traded up $2.48 during mid-day trading on Monday, reaching $205.51. 1,781,515 shares of the company were exchanged, compared to its average volume of 1,718,708. Allstate has a 1 year low of $169.20 and a 1 year high of $213.18. The firm's 50-day simple moving average is $198.36 and its 200 day simple moving average is $197.41. The firm has a market cap of $54.15 billion, a price-to-earnings ratio of 9.66, a P/E/G ratio of 0.87 and a beta of 0.35. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43.

Allstate Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be paid a dividend of $1.00 per share. The ex-dividend date is Friday, August 29th. This represents a $4.00 annualized dividend and a dividend yield of 1.9%. Allstate's dividend payout ratio is 18.81%.

Institutional Investors Weigh In On Allstate

Hedge funds have recently made changes to their positions in the business. Bank of America Corp DE lifted its stake in shares of Allstate by 157.9% in the 4th quarter. Bank of America Corp DE now owns 6,591,138 shares of the insurance provider's stock worth $1,270,705,000 after acquiring an additional 4,035,629 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Allstate by 25.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider's stock worth $2,424,710,000 after acquiring an additional 2,374,684 shares during the period. Boston Partners lifted its stake in shares of Allstate by 613.9% in the 1st quarter. Boston Partners now owns 2,482,654 shares of the insurance provider's stock worth $512,627,000 after acquiring an additional 2,134,893 shares during the period. GAMMA Investing LLC increased its holdings in shares of Allstate by 25,026.1% in the 1st quarter. GAMMA Investing LLC now owns 1,273,895 shares of the insurance provider's stock valued at $263,785,000 after purchasing an additional 1,268,825 shares in the last quarter. Finally, Castle Hook Partners LP increased its holdings in shares of Allstate by 1,303.3% in the 4th quarter. Castle Hook Partners LP now owns 824,838 shares of the insurance provider's stock valued at $159,021,000 after purchasing an additional 766,058 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.